Notícias
Comunicados de imprensa da Accuray
Os comunicados à imprensa mais recentes da Accuray, com destaques sobre nossa empresa e nossas tecnologias de radioterapia.
- Accuray and the University of Wisconsin-Madison Announce Master Research Agreement to Improve Personalized Care for Patients with Cancer
MADISON, Wis., May 15, 2026 /PRNewswire/ -- Accuray Incorporated (NASDAQ: ARAY) and the University of Wisconsin School of Medicine and Public Health (UW SMPH) announced a new 10‑year strategic collaboration to advance personalized cancer treatments using Accuray's Stellar™ adaptive radiation
- Accuray Reports Fiscal 2026 Third Quarter Financial Results
MADISON, Wis., May 6, 2026 /PRNewswire/ -- Accuray Incorporated (NASDAQ: ARAY) today reported financial results for the third quarter ended March 31, 2026. Key Highlights Transformation plan delivering ahead of expectations, with approximately $10 million of cost and margin improvements
- Accuray to Report Third Quarter Fiscal 2026 Financial Results on May 6, 2026
MADISON, Wis., April 22, 2026 /PRNewswire/ -- Accuray Incorporated (NASDAQ: ARAY) will report financial results for the third quarter of fiscal year 2026, ended March 31, 2026, during a conference call hosted by company management at 1:30 p.m. PT / 4:30 p.m. ET on May 6, 2026.
- Accuray Appoints Paul Miele as Senior Vice President and Chief Commercial Officer
MADISON, Wis., April 6, 2026 /PRNewswire/ -- Accuray Incorporated (NASDAQ: ARAY), a leading provider of radiation therapy systems for cancer treatment, today announced the appointment of Paul Miele as Senior Vice President and Chief Commercial Officer, effective April 6, 2026.
- Accuray Reports Fiscal 2026 Second Quarter Financial Results
MADISON, Wis., Feb. 4, 2026 /PRNewswire/ -- Accuray Incorporated (NASDAQ: ARAY) today reported financial results for the second quarter ended December 31, 2025. Key Highlights On December 15, 2025 the Company announced the first phase of comprehensive, strategic, operational, and
